Literature DB >> 18221623

Scopolamine as an antidepressant agent: theoretical and treatment considerations.

David S Janowsky1.   

Abstract

Entities:  

Year:  2007        PMID： 18221623     DOI： 10.1007/s11920-007-0060-4

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  5 in total

1.  The effects of acute scopolamine in geriatric depression.

Authors:  P A Newhouse; T Sunderland; P N Tariot; H Weingartner; K Thompson; A M Mellow; R M Cohen; D L Murphy
Journal:  Arch Gen Psychiatry       Date:  1988-10

2.  A cholinergic-adrenergic hypothesis of mania and depression.

Authors:  D S Janowsky; M K el-Yousef; J M Davis; H J Sekerke
Journal:  Lancet       Date:  1972-09-23       Impact factor: 79.321

3.  Acetylcholine and depression.

Authors:  D S Janowsky; M K el-Yousef; J M Davis
Journal:  Psychosom Med       Date:  1974 May-Jun       Impact factor: 4.312

4.  The cholinolytic biperiden in depression. An acute placebo controlled study.

Authors:  H Beckmann; H W Moises
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

5.  The effects of scopolamine on sleep and mood in depressed patients with a history of alcoholism and a normal comparison group.

Authors:  J C Gillin; L Sutton; C Ruiz; D Darko; S Golshan; S C Risch; D Janowsky
Journal:  Biol Psychiatry       Date:  1991-07-15       Impact factor: 13.382
  5 in total
  1 in total

Review 1.  Depression and antidepressants: molecular and cellular aspects.

Authors:  Cristina Lanni; Stefano Govoni; Adele Lucchelli; Cinzia Boselli
Journal:  Cell Mol Life Sci       Date:  2009-06-12       Impact factor: 9.261
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.